Strategies for using nanoprobes to perceive and treat cancer activity: a review.
Nanomedicine has seen a significant increase in research on stimuli-responsive activatable nanoprobes for tumor-specific delivery and diagnosis. The tumor microenvironment has particular characteristics that can be exploited to implement therapeutic strategies based on disparities between normal tissues and tumor tissues, including differences in pH, oxygenation, enzymatic expression, gene activation/inactivation, and vasculature. The nanocarriers of activatable nanoparticles maintain their structure while circulating in the body and, upon reaching the tumor site, are altered by unique tumoral stimuli, leading to the release of a drug or other agent. This review demonstrates the latest achievements in the use of internal stimuli-responsive, activatable nanoparticles with respect to unique design strategies and applications.
Department of Chemical and Biomolecular Engineering, Yonsei University, 50 Yonsei-ro, Seoul, Korea.
Byunghoon
B
Kang
Department of Chemical and Biomolecular Engineering, Yonsei University, 50 Yonsei-ro, Seoul, Korea.
Aastha
A
Kukreja
College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong, Korea.
Daesub
D
Song
Department of Radiology, Yonsei University, 50 Yonsei-ro, Seoul, Korea.
Yong-Min
YM
Huh
Department of Chemical and Biomolecular Engineering, Yonsei University, 50 Yonsei-ro, Seoul, Korea.
Seungjoo
S
Haam
Cancer activity; Nanoparticles; Stimuli responsive